Management of a primary malignant melanoma of uterine cervix stage IVA patient with radical surgery and adjuvant oncolytic virus Rigvir<sup>®</sup> therapy: A case report
Elizabete Pumpure(Riga Stradiņš University), Simona Doniņa(Children's Clinical University Hospital), Pēteris Alberts(Maxygen (United States)), Agnija Rasa, Dana Kigitoviča, I. Nemiro(Latvian Biomedical Research and Study Centre), Tatjana Zablocka(Riga East University Hospital), Sergejs Isajevs(Riga East University Hospital), Evija Olmane(Pauls Stradiņš Clinical University Hospital), Eva Dručka(Riga Stradiņš University), Raimundas Meškauskas(Vilnius University)
Cited by 5
Related Papers
Selective Inhibition of 11β-Hydroxysteroid Dehydrogenase Type 1 Improves Hepatic Insulin Sensitivity in Hyperglycemic Mice Strains
|Endocrinology|2003|263
Selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic mice
|Diabetologia|2002|259
Arylsulfonamidothiazoles as a New Class of Potential Antidiabetic Drugs. Discovery of Potent and Selective Inhibitors of the 11β-Hydroxysteroid Dehydrogenase Type 1
|Journal of Medicinal Chemistry|2002|211
The advent of oncolytic virotherapy in oncology: The Rigvir® story
|European Journal of Pharmacology|2018|179